Submission Details
| 510(k) Number | K203569 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | December 07, 2020 |
| Decision Date | June 11, 2021 |
| Days to Decision | 186 days |
| Submission Type | Traditional |
| Review Panel | Ophthalmic (OP) |
| Summary | Summary PDF |
K203569 is an FDA 510(k) clearance for the Gold Tapered Weight Eyelid Implants, Platinum Tapered Weight Eyelid Implants, a Weights, Eyelid, Implantable (Class II — Special Controls, product code NCB), submitted by Fci (France Chirurgie Instrumentation) Sas (Paris, FR). The FDA issued a Cleared decision on June 11, 2021, 186 days after receiving the submission on December 7, 2020. This device falls under the Ophthalmic review panel. Regulated under 21 CFR 886.5700.
| 510(k) Number | K203569 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | December 07, 2020 |
| Decision Date | June 11, 2021 |
| Days to Decision | 186 days |
| Submission Type | Traditional |
| Review Panel | Ophthalmic (OP) |
| Summary | Summary PDF |
| Product Code | NCB — Weights, Eyelid, Implantable |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 886.5700 |
| Definition | Gravity Assisted Treatment Of Lagophthalmos (incomplete Eyelid Closure) |